黄宗银. 老年重症心力衰竭早期血小板和淋巴细胞比值与近期主要不良心脑血管事件的相关性分析[J]. 中国急救医学, 2018, 38(1): 31-36.
Huang Zong-yin. Correlation analysis of platelet-to-lymphocyte ratio and recent major adverse cardiac and cerebrovascular events in patients with severe heart failure. Chinese Journal of Critical Care Medicine, 2018, 38(1): 31-36.
[1]Burkhoff D, Maurer MS, Joseph SM, et al. Left atrial decompression pump for severe heart failure with preserved ejection fraction: theoretical and clinical considerations [J]. JACC Heart Fail, 2015, 3(4):275-282.
[2]Campana M, Scotti C, Domenighini D, et al. Serial echocardiographic examinations and prognosis in patients with severe heart failure[J]. European Journal of Heart Failure, 2015, 2(S1):111.
[3]Palau P, Domínguez E, Núez E, et al. Six-minute walk test in moderate to severe heart failure with preserved ejection fraction: Useful for functional capacity assessment[J]. Int J Cardiol, 2016, 203:800-802.
[4]中华医学会心血管病学分会,中华心血管病杂志编辑委员会. 中国心力衰竭诊断和治疗指南(2014) [J]. 中华心血管病杂志, 2014, 42(2): 98-122.
[5]Ghaffari S, Nadiri M, Pourafkari L, et al. The predictive Value of Total Neutrophil Count and Neutrophil/Lymphocyte Ratio in Predicting Inhospital Mortality and Complications after STEMI[J]. J Cardiovasc Thorac Res, 2014, 6(1): 35-41.
[6]魏新考, 李亚昭, 崔利锋. 糖皮质激素辅助治疗对重症心力衰竭患者心功能及血浆皮质醇、脑钠肽的影响[J]. 医学综述, 2017, 23(3):581-584.
[7]Eschalier R , Chenaf C, Mulliez A, et al. Impact of clinical characteristics and management on the prognosis of unselected heart failure patients [J]. Cardiovasc Drugs Ther, 2015, 29(1):89-98.
[8]Kurtul A, Murat SN, Yarlioglues M, et al. Association of platelet-to-lymphocyte ratio with severity and complexity of coronary artery disease in patients with acute coronary syndromes[J]. Am J Cardiol, 2014, 114(7): 972-978.
[9]黄冠华, 闫旭龙, 王增帅. 血小板与淋巴细胞比值与冠心病患者经皮冠状动脉介入治疗术后预后的关系研究[J]. 中国全科医学, 2016(12):33-35. 没有
[10]Osadnik T, Wasilewski J, Lekston A, et al. The platelet-to-lymphocyte ratio as a predictor of all-cause mortality in patients with coronary artery disease undergoing elective percutaneous coronary intervention and stent implantation [J]. J Saudi Heart Assoc, 2015, 27(3):144-151.
[11]Ozcan Cetin EH, Cetin MS, Aras D, et al. Platelet to lymphocyte ratio as a prognostic marker of in-hospital and long termmajor adverse cardiovascular events in ST-segment elevation myocardial infarction [J]. Angiology, 2016, 67( 4) : 336-345.
[12]Balci KG, Balci MM, Arslan U, et al. Increased Platelet-to-Lymphocyte Ratios and Low Relative Lymphocyte Counts Predict Appropriate Shocks in Heart Failure Patients with ICDs[J]. Acta Cardiol Sin, 2016, 32(5):542-549.
[13]Trofimov ES, Poskrebysheva AS. Study on activity of inflammatory factors in patients with chronic heart failure depending on the stage of the disease and NYHA class [J]. Bull Exp Biol Med, 2015, 158(5):614-616.
[14]Canada MN, Fronk DT, Cei LF, et al. Usefulness of C-Reactive Protein Plasma Levels to Predict Exercise Intolerance in Patients With Chronic Systolic Heart Failure[J]. Am J Cardiol, 2016, 117(1):116-120.
[15]迪丽达尔·希力甫, 阿米娜·阿迪力, 赵龙,等. 老年慢性心衰患者高尿酸血症及高凝状态的相关性分析[J]. 新疆医科大学学报, 2015, 38(8):999-1001.
[16]Mongirdiene A, Kursvietiene L, Kasauskas A. The coagulation system changes in patients with chronic heart failure [J]. Medicina (Kaunas) , 2010, 46(9):642-647.
[17]Yan W, Liu C, Li R, et al. Usefulness of the Neutrophil-to-Lymphocyte Ratio in Predicting Adverse Events in Elderly Patients With Chronic Heart Failure[J]. Int Heart J, 2016, 57(5):615-621.
[18]Wiwanitkit V. Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio and Heart Failure[J]. Arq Bras Cardiol, 2016, 106(3):265.